116 related articles for article (PubMed ID: 37766469)
21. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
22. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
[TBL] [Abstract][Full Text] [Related]
23. A large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.
Hu HH; Benfodda M; Dumaz N; Gazal S; Descamps V; Bourillon A; Basset-Seguin N; Riffault A; Ezzedine K; Bagot M; Bensussan A; Saiag P; Grandchamp B; Soufir N
Biomed Res Int; 2014; 2014():925716. PubMed ID: 24982914
[TBL] [Abstract][Full Text] [Related]
24. A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.
Salgado C; Kwesi-Maliepaard EM; Jochemsen AG; Visser M; Harland M; van Leeuwen F; van Doorn R; Gruis N
Melanoma Res; 2019 Dec; 29(6):582-589. PubMed ID: 31524790
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
26. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
27. GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients.
Dunjic M; Lukic N; Djordjevic B; Uzelac B; Ostojic N; Supic G
Melanoma Res; 2022 Feb; 32(1):11-17. PubMed ID: 34939981
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
29. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
30. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
[TBL] [Abstract][Full Text] [Related]
31. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
Jackson S; Harland M; Turner F; Taylor C; Chambers PA; Randerson-Moor J; Swerdlow AJ; dos Santos Silva I; Beswick S; Bishop DT; Newton Bishop JA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):913-8. PubMed ID: 15824163
[TBL] [Abstract][Full Text] [Related]
32. Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.
Yepes S; Tucker MA; Koka H; Xiao Y; Zhang T; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Hutchinson A; Yeager M; Hicks B; Brown KM; Freedman ND; Chanock SJ; Goldstein AM; Yang XR
J Invest Dermatol; 2022 Sep; 142(9):2464-2475.e5. PubMed ID: 35181301
[TBL] [Abstract][Full Text] [Related]
33. The genetics of susceptibility to cutaneous melanoma.
Newton Bishop JA; Bishop DT
Drugs Today (Barc); 2005 Mar; 41(3):193-203. PubMed ID: 15883616
[TBL] [Abstract][Full Text] [Related]
34. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
35. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
[TBL] [Abstract][Full Text] [Related]
36. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
37. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
[TBL] [Abstract][Full Text] [Related]
38. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
[TBL] [Abstract][Full Text] [Related]
39. Germline melanoma susceptibility and prognostic genes: a review of the literature.
Ward KA; Lazovich D; Hordinsky MK
J Am Acad Dermatol; 2012 Nov; 67(5):1055-67. PubMed ID: 22583682
[TBL] [Abstract][Full Text] [Related]
40. Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility.
Yepes S; Tucker MA; Koka H; Xiao Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Hutchinson A; Yeager M; Hicks B; Freedman ND; Chanock SJ; Goldstein AM; Yang XR
Sci Rep; 2020 Oct; 10(1):17198. PubMed ID: 33057211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
